Eric Langewisch is a Nephrology physician affiliated with University of Nebraska Medical Center. OpenAlex indexes 16 publications with 322 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Emile 42nd St
Omaha, NE 681980001
Telephone
402-559-4015Registry record last updated 6 Aug 2016.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Biogen, Inc.Program year20251 payment
- CSL BehringProgram year202211 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
51.3%Beta blocker17.3%Carvedilol69%Metoprolol Tartrate17%Metoprolol Succinate9%Propranolol Hcl6%Part D<11 patientsCalcium channel blocker10.4%Nifedipine Er60%Amlodipine Besylate40%Part D≥30 patients+ 8 more classes in this area
Metabolism & gastrointestinal
35.3%Corticosteroid22.5%Prednisone100%Part D≥100 patientsProton pump inhibitor7.6%Pantoprazole Sodium67%Omeprazole33%Part D≥26 patients+ 2 more classes in this area
Anti-infectives
3.6%Short-acting sulfonamides2.7%Sulfamethoxazole-Trimethoprim100%Part D<11 patientsCytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor0.9%Valganciclovir Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Successful Living Related Kidney Transplant Alone in a Patient with Noncirrhotic Portal Hypertension
Journal of the American Society of Nephrology
2025 - Impact of Induction Therapy on Infectious Complications in Simultaneous Liver-Kidney Transplant Recipients
American Journal of Transplantation
2025 - Kidney Transplant Candidacy: Addressing Common Medical and Psychosocial Barriers to Transplant
Advances in Kidney Disease and Health
2024
Similar KOLs
Other experts from the same institution or the same specialty.
James Armitage, MD
University of Nebraska Medical Center
Julie Vose, MD
University of Nebraska Medical Center
Kathleen Moore, MD
University of Nebraska Medical Center
Ted Mikuls, MD
University of Nebraska Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”